113 related articles for article (PubMed ID: 34487019)
1. Delta-like ligand 4 level in colorectal cancer is associated with tumor aggressiveness and clinical outcome.
Zhang Z; Li X; Yan X; Qiu H; Li G; Guo X; Lu Y; Yang J; Jiao M; Chen X; Zhu S; Dang C; Wang W; Chu D
Cancer Biomark; 2022; 33(3):415-422. PubMed ID: 34487019
[TBL] [Abstract][Full Text] [Related]
2. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
[TBL] [Abstract][Full Text] [Related]
3. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
[TBL] [Abstract][Full Text] [Related]
4. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.
Qiu XX; Chen L; Wang CH; Lin ZX; Zhou CF; Liu SY; Wang XF; Chen YP
Medicine (Baltimore); 2014 Aug; 93(8):e57. PubMed ID: 25121357
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.
Xiao M; Yang S; Ning X; Huang Y
Hum Pathol; 2014 Nov; 45(11):2302-10. PubMed ID: 25260720
[TBL] [Abstract][Full Text] [Related]
6. Correlation of high delta-like ligand 4 expression with peritumoral brain edema and its prediction of poor prognosis in patients with primary high-grade gliomas.
Qiu XX; Wang CH; Lin ZX; You N; Wang XF; Chen YP; Chen L; Liu SY; Kang DZ
J Neurosurg; 2015 Dec; 123(6):1578-85. PubMed ID: 26047413
[TBL] [Abstract][Full Text] [Related]
7. Low HES-1 and positive DLL4 expression predicts poor prognosis of colorectal cancers.
Kim G; Jung J; Kim JW; Kim JY
Pathology; 2023 Feb; 55(1):52-57. PubMed ID: 36167746
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
[TBL] [Abstract][Full Text] [Related]
9. Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium.
Hirano KI; Hosokawa H; Yahata T; Ando K; Tanaka M; Imai J; Yazawa M; Ohtsuka M; Negishi N; Habu S; Sato T; Hozumi K
Front Immunol; 2022; 13():852427. PubMed ID: 35371023
[TBL] [Abstract][Full Text] [Related]
10. Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis.
Chen L; Gu T; Li B; Li F; Ma Z; Zhang Q; Cai X; Lu L
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1663-1675. PubMed ID: 31233801
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Yoon HA; Noh MH; Kim BG; Han JS; Jang JS; Choi SR; Jeong JS; Chun JH
World J Gastroenterol; 2011 Sep; 17(35):4023-30. PubMed ID: 22046092
[TBL] [Abstract][Full Text] [Related]
12. Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer.
Wang L; Cao G; Li W; Chen XW; Xiong SS; Mu YN; Jiang JF; Yang L; Zhang DR; Cao YW
Technol Cancer Res Treat; 2023; 22():15330338221118984. PubMed ID: 36740988
[No Abstract] [Full Text] [Related]
13. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.
Benedito R; Roca C; Sörensen I; Adams S; Gossler A; Fruttiger M; Adams RH
Cell; 2009 Jun; 137(6):1124-35. PubMed ID: 19524514
[TBL] [Abstract][Full Text] [Related]
14. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.
Zhang JX; Cai MB; Wang XP; Duan LP; Shao Q; Tong ZT; Liao DZ; Li YY; Huang MY; Zeng YX; Shao JY
Med Oncol; 2013 Mar; 30(1):390. PubMed ID: 23275120
[TBL] [Abstract][Full Text] [Related]
15. The notch ligand delta-like 4 regulates multiple stages of early hemato-vascular development.
Laranjeiro R; Alcobia I; Neves H; Gomes AC; Saavedra P; Carvalho CC; Duarte A; Cidadão A; Parreira L
PLoS One; 2012; 7(4):e34553. PubMed ID: 22514637
[TBL] [Abstract][Full Text] [Related]
16. Increased cytoplasmic expression of DLL4 is associated with favorable prognosis in colorectal cancer.
Naseri M; Saeednejad Zanjani L; Vafaei S; Gheytanchi E; Abolhasani M; Bozorgmehr M; Ranaei Pirmardan E; Ghods R; Madjd Z
Future Oncol; 2021 Aug; 17(24):3231-3242. PubMed ID: 34156260
[No Abstract] [Full Text] [Related]
17. Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.
Rajabi A; Saber A; Pourmahdi M; Emami A; Ravanbakhsh R; Khodavirdipour A; Khodaei M; Akbarzadeh M; Abdolahi S; Hosseinpourfeizi MA; Safaralizadeh R
Recent Pat Anticancer Drug Discov; 2020; 15(4):329-340. PubMed ID: 32990541
[TBL] [Abstract][Full Text] [Related]
18. Mammalian Numb protein antagonizes Notch by controlling postendocytic trafficking of the Notch ligand Delta-like 4.
Shao X; Ding Z; Zhao M; Liu K; Sun H; Chen J; Liu X; Zhang Y; Hong Y; Li H; Li H
J Biol Chem; 2017 Dec; 292(50):20628-20643. PubMed ID: 29042443
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of DLL4 expression in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Okumura H; Kurahara H; Uchikado Y; Setoyama T; Kita Y; Kijima Y; Nishizono Y; Nakajo A; Owaki T; Ueno S; Natsugoe S
J Exp Clin Cancer Res; 2013 Jul; 32(1):46. PubMed ID: 23898884
[TBL] [Abstract][Full Text] [Related]
20. Delta-like ligand 4-notch blockade and tumor radiation response.
Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
